Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Cardiac Rehabilitation Use After Percutaneous Coronary Intervention.

Sukul D, Seth M, Barnes GD, Dupree JM, Syrjamaki JD, Dixon SR, Madder RD, Lee D, Gurm HS.

J Am Coll Cardiol. 2019 Jun 25;73(24):3148-3152. doi: 10.1016/j.jacc.2019.03.515. No abstract available.

PMID:
31221264
2.

Upstream Impact of Public Reporting.

Gupta A, Gurm HS, Kirtane AJ.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007878. doi: 10.1161/CIRCINTERVENTIONS.119.007878. No abstract available.

PMID:
30998387
3.

Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes.

Chui PW, Parzynski CS, Ross JS, Desai NR, Gurm HS, Spertus JA, Seto AH, Ho V, Curtis JP.

J Am Heart Assoc. 2019 Jan 22;8(2):e010373. doi: 10.1161/JAHA.118.010373.

4.

Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.

Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS.

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004817. doi: 10.1161/CIRCOUTCOMES.118.004817.

PMID:
30636483
5.

Drivers of Variation in 90-Day Episode Payments After Percutaneous Coronary Intervention.

Sukul D, Seth M, Dupree JM, Syrjamaki JD, Ryan AM, Nallamothu BK, Gurm HS.

Circ Cardiovasc Interv. 2019 Jan;12(1):e006928. doi: 10.1161/CIRCINTERVENTIONS.118.006928.

PMID:
30608883
6.

Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.

Fanaroff AC, Zakroysky P, Wojdyla D, Kaltenbach LA, Sherwood MW, Roe MT, Wang TY, Peterson ED, Gurm HS, Cohen MG, Messenger JC, Rao SV.

Circulation. 2019 Jan 22;139(4):458-472. doi: 10.1161/CIRCULATIONAHA.117.033325.

PMID:
30586696
7.

Left Main Stenting: Joining the Mainstream.

Gurm HS.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2492-2494. doi: 10.1016/j.jcin.2018.10.035. No abstract available.

PMID:
30573060
8.

Temporal Trends in Unstable Angina Diagnosis Codes for Outpatient Percutaneous Coronary Interventions.

Wadhera RK, Sukul D, Secemsky EA, Shen C, Gurm HS, Boden WE, Yeh RW.

JAMA Intern Med. 2019 Feb 1;179(2):259-261. doi: 10.1001/jamainternmed.2018.5124. No abstract available.

PMID:
30556822
9.

Pre-hospital Transport Times and Outcomes After Different Reperfusion Strategies for ST-Elevation Myocardial Infarction.

Andersson HB, Seth M, Gurm HS, Bates ER.

Am J Cardiol. 2019 Feb 1;123(3):375-381. doi: 10.1016/j.amjcard.2018.10.015. Epub 2018 Oct 21.

PMID:
30545480
10.

Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.

Gurm HS, Mavromatis K, Bertolet B, Kereiakes DJ, Amin AP, Shah AP, Hanzel GS, Rao S, Thomas JL, Kumar G.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1228-1235. doi: 10.1002/ccd.27935. Epub 2018 Nov 4.

PMID:
30393942
11.

Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.

Gurm HS, Seth M, Dixon SR, Michael Grossman P, Sukul D, Lalonde T, Cannon L, West D, Madder RD, Adam Lauver D.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):222-230. doi: 10.1002/ccd.27819. Epub 2018 Aug 25.

PMID:
30144337
12.

Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.

Mehran R, Faggioni M, Chandrasekhar J, Angiolillo DJ, Bertolet B, Jobe RL, Al-Joundi B, Brar S, Dangas G, Batchelor W, Prasad A, Gurm HS, Tumlin J, Stone GW.

JACC Cardiovasc Interv. 2018 Aug 27;11(16):1601-1610. doi: 10.1016/j.jcin.2018.04.007.

PMID:
30139467
13.

Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Song C, Sukul D, Seth M, Wohns D, Dixon SR, Slocum NK, Gurm HS.

Circ Cardiovasc Interv. 2018 Jun;11(6):e006400. doi: 10.1161/CIRCINTERVENTIONS.118.006400.

PMID:
29895601
14.

Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals.

Alyesh DM, Seth M, Miller DC, Dupree JM, Syrjamaki J, Sukul D, Dixon S, Kerr EA, Gurm HS, Nallamothu BK.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004328. doi: 10.1161/CIRCOUTCOMES.117.004328.

PMID:
29853465
15.

Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2).

Gurm HS, Seth M, Dixon S, Kraft P, Jensen A.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):509-511. doi: 10.1016/j.jcin.2017.10.018. No abstract available.

16.

Early Outcomes following Endovascular, Open Surgical, and Hybrid Revascularization for Lower Extremity Acute Limb Ischemia.

Davis FM, Albright J, Gallagher KA, Gurm HS, Koenig GC, Schreiber T, Grossman PM, Henke PK.

Ann Vasc Surg. 2018 Aug;51:106-112. doi: 10.1016/j.avsg.2017.12.025. Epub 2018 Mar 5.

PMID:
29518503
17.

Association Between Medicaid Expansion and Cardiovascular Interventions in Michigan.

Likosky DS, Sukul D, Seth M, He C, Gurm HS, Prager RL.

J Am Coll Cardiol. 2018 Mar 6;71(9):1050-1051. doi: 10.1016/j.jacc.2017.12.044. No abstract available.

18.

Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.

Sukul D, Bhatt DL, Seth M, Zakroysky P, Wojdyla D, Rumsfeld JS, Wang T, Rao SV, Gurm HS.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.

19.

Computational Fluid Dynamics Modeling of the Burr Orbital Motion in Rotational Atherectomy with Particle Image Velocimetry Validation.

Zheng Y, Liu Y, Pitre JJ, Bull JL, Gurm HS, Shih AJ.

Ann Biomed Eng. 2018 Apr;46(4):567-578. doi: 10.1007/s10439-018-1984-z. Epub 2018 Jan 24.

PMID:
29368259
20.

Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC).

Ambulgekar NV, Grey SF, Rosman HS, Othman H, Davis TP, Nypaver TJ, Schreiber T, Yamasaki H, Lalonde TA, Henke PK, Gurm HS, Mehta RH, Grossman PM; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Investigators.

J Invasive Cardiol. 2018 Jan;30(1):35-42.

21.

Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Afana M, Gurm HS, Seth M, Frazier KM, Fielding S, Koenig GC.

Am Heart J. 2018 Jan;195:99-107. doi: 10.1016/j.ahj.2017.10.004. Epub 2017 Oct 14.

PMID:
29224652
22.

Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia.

Sukul D, Grey SF, Henke PK, Gurm HS, Grossman PM.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2307-2316. doi: 10.1016/j.jcin.2017.08.026.

23.

Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry.

Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2242-2254. doi: 10.1016/j.jcin.2017.07.020. Epub 2017 Nov 1.

24.

Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium).

Song C, Sukul D, Seth M, Dupree JM, Khandelwal A, Dixon SR, Wohns D, LaLonde T, Gurm HS.

Am J Cardiol. 2017 Dec 1;120(11):1926-1932. doi: 10.1016/j.amjcard.2017.08.009. Epub 2017 Aug 30.

PMID:
29025684
25.

Changes in Primary Noncardiac Diagnoses Over Time Among Elderly Cardiac Intensive Care Unit Patients in the United States.

Sinha SS, Sjoding MW, Sukul D, Prescott HC, Iwashyna TJ, Gurm HS, Cooke CR, Nallamothu BK.

Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8):e003616. doi: 10.1161/CIRCOUTCOMES.117.003616.

26.

Hydration and contrast-induced kidney injury.

Gurm HS, Dixon S.

Lancet. 2017 Jul 29;390(10093):452-453. doi: 10.1016/S0140-6736(17)31812-3. Epub 2017 Jul 27. No abstract available.

PMID:
28792405
27.

P2Y12 Inhibitors in Patients With Chronic Kidney Disease: The Known Unknown.

Gurm HS.

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2026-2028. doi: 10.1016/j.jcin.2017.06.028. Epub 2017 Aug 2. No abstract available.

28.

Spectrum of atrial arrhythmias using the ligament of Marshall in patients with atrial fibrillation.

Chugh A, Gurm HS, Krishnasamy K, Saeed M, Lohawijarn W, Hornsby K, Cunnane R, Ghanbari H, Latchamsetty R, Crawford T, Jongnarangsin K, Bogun F, Oral H, Morady F.

Heart Rhythm. 2018 Jan;15(1):17-24. doi: 10.1016/j.hrthm.2017.07.033. Epub 2017 Jul 29.

PMID:
28765086
29.

Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.

Fanaroff AC, Zakroysky P, Dai D, Wojdyla D, Sherwood MW, Roe MT, Wang TY, Peterson ED, Gurm HS, Cohen MG, Messenger JC, Rao SV.

J Am Coll Cardiol. 2017 Jun 20;69(24):2913-2924. doi: 10.1016/j.jacc.2017.04.032.

30.

The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Sukul D, Seth M, Schreiber T, Hanzel G, Khandelwal A, Cannon LA, Lalonde TA, Gurm HS.

J Interv Cardiol. 2017 Aug;30(4):291-300. doi: 10.1111/joic.12388. Epub 2017 May 22.

31.

Non-Invasive Thrombolysis Using Microtripsy in a Porcine Deep Vein Thrombosis Model.

Zhang X, Macoskey JJ, Ives K, Owens GE, Gurm HS, Shi J, Pizzuto M, Cain CA, Xu Z.

Ultrasound Med Biol. 2017 Jul;43(7):1378-1390. doi: 10.1016/j.ultrasmedbio.2017.01.028. Epub 2017 Apr 28.

33.

Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.

Vora AN, Stanislawski M, Grunwald GK, Plomondon ME, Rumsfeld JS, Maddox TM, Vidovich MI, Woody W, Nallamothu BK, Gurm HS, Rao SV.

J Am Heart Assoc. 2017 Apr 18;6(4). pii: e004819. doi: 10.1161/JAHA.116.004819.

34.

Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Grossman PM, Ali SS, Aronow HD, Boros M, Nypaver TJ, Schreiber TL, Park YJ, Henke PK, Gurm HS.

J Interv Cardiol. 2017 Jun;30(3):274-280. doi: 10.1111/joic.12379. Epub 2017 Apr 3.

35.

Coronary Stents in Diabetic Patients: State of the Knowledge.

Codner P, Gurm HS, Motivala A.

Curr Cardiol Rep. 2017 Apr;19(4):28. doi: 10.1007/s11886-017-0837-y. Review.

PMID:
28315123
36.

The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.

Sukul D, Seth M, Schreiber T, Khandelwal A, Cannon LA, LaLonde TA, Gurm HS.

Catheter Cardiovasc Interv. 2017 Nov 1;90(5):724-732. doi: 10.1002/ccd.27001. Epub 2017 Mar 17.

37.

Root Cause Analysis of Deaths in ST-Segment Elevation Myocardial Infarctions Treated With Primary PCI: What Can We Do Better?

El Sakr F, Kenaan M, Menees D, Seth M, Gurm HS.

J Invasive Cardiol. 2017 May;29(5):164-168. Epub 2017 Mar 15.

38.

Temporal trends in peripheral arterial interventions: Observations from the blue cross blue shield of michigan cardiovascular consortium (BMC2 PVI).

Thomas MP, Jung Park Y, Grey S, Schreiber TL, Gurm HS, Leffler D, Davis TP, Henke P, Michael Grossman P.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):728-734. doi: 10.1002/ccd.26883. Epub 2017 Feb 27.

39.

Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.

Parsh J, Seth M, Green J, Sutton NR, Chetcuti S, Dixon S, Grossman PM, Khandelwal A, Dupree JM, Gurm HS.

Catheter Cardiovasc Interv. 2017 May;89(6):966-973. doi: 10.1002/ccd.26917. Epub 2017 Feb 1.

40.

A digital tool for incorporating right atrial pressure into fractional flow reserve determination.

Meah S, Gurm HS.

Catheter Cardiovasc Interv. 2018 Sep 1;92(3):E204-E205. doi: 10.1002/ccd.26820. Epub 2016 Nov 25. No abstract available.

PMID:
27885795
41.

The Association of Peri-Procedural Blood Transfusion with Morbidity and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC.

Henke PK, Park YJ, Hans S, Bove P, Cuff R, Kazmers A, Schreiber T, Gurm HS, Grossman PM.

PLoS One. 2016 Nov 11;11(11):e0165796. doi: 10.1371/journal.pone.0165796. eCollection 2016.

42.

Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.

Sukul D, Seth M, Dixon SR, Zainea M, Slocum NK, Pielsticker EJ, Gurm HS.

Catheter Cardiovasc Interv. 2017 Jul;90(1):94-101. doi: 10.1002/ccd.26781. Epub 2016 Sep 21.

43.

Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Sutton NR, Seth M, Ruwende C, Gurm HS.

J Am Coll Cardiol. 2016 Aug 30;68(9):895-904. doi: 10.1016/j.jacc.2016.05.085.

44.

The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions.

Parsh J, Seth M, Briguori C, Grossman P, Solomon R, Gurm HS.

Am Heart J. 2016 May;175:160-7. doi: 10.1016/j.ahj.2016.02.013. Epub 2016 Feb 27.

PMID:
27179735
45.

Histotripsy Thrombolysis on Retracted Clots.

Zhang X, Owens GE, Cain CA, Gurm HS, Macoskey J, Xu Z.

Ultrasound Med Biol. 2016 Aug;42(8):1903-18. doi: 10.1016/j.ultrasmedbio.2016.03.027. Epub 2016 May 7.

46.

A data driven approach for optimizing cardiac care: Acute coronary syndromes and beyond.

Gurm HS.

Indian Heart J. 2016 Mar-Apr;68(2):114-7. doi: 10.1016/j.ihj.2015.09.011. Epub 2016 Jan 13. No abstract available.

47.

Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.

Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, McCabe JM, Resnic FS, Gurm HS, Yeh RW.

Circ Cardiovasc Interv. 2016 Apr;9(4):e003464. doi: 10.1161/CIRCINTERVENTIONS.115.003464.

48.

Impact of institutional culture on rates of transfusions during cardiovascular procedures: The Michigan experience.

Likosky DS, Zhang M, Paone G, Collins J, DeLucia A 3rd, Schreiber T, Theurer P, Kazziha S, Leffler D, Wunderly DJ, Gurm HS, Prager RL; Blue Cross and Blue Shield of Michigan Percutaneous Coronary Interventions Collaborative; Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative.

Am Heart J. 2016 Apr;174:1-6. doi: 10.1016/j.ahj.2015.12.019. Epub 2016 Jan 6.

PMID:
26995363
49.

Can our choice of contrast media impact renal and cardiovascular outcomes?

Prasad A, Gurm HS.

Catheter Cardiovasc Interv. 2016 Mar;87(4):710-1. doi: 10.1002/ccd.26483.

50.

Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.

Khambatta S, Othman H, Seth M, Lalonde T, Rosman HS, Gurm HS, Mehta RH; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Investigators.

Cardiovasc Revasc Med. 2016 Jun;17(4):233-40. doi: 10.1016/j.carrev.2016.02.014. Epub 2016 Feb 27.

PMID:
26994504

Supplemental Content

Support Center